Cleared Traditional

Xerxes Hip Stem (K231109) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K231109 · Xerxes Arthopedix, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
57d
Days
Class 2
Risk

K231109 is an FDA 510(k) clearance for the Xerxes Hip Stem. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Xerxes Arthopedix, LLC (Naples, US). The FDA issued a Cleared decision on June 15, 2023 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Xerxes Arthopedix, LLC devices

Submission Details

510(k) Number K231109 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 19, 2023
Decision Date June 15, 2023
Days to Decision 57 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 122d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 291
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K231109.
EMPHASYS Femoral Stems
K233233 · Depuy Ireland UC · Oct 2023
MINIMA S System
K231925 · Lima Corporate S.P.A. · Jul 2023
BethaLoc® stem cementless HA
K223103 · Implantcast GmbH · Jun 2023
Exactech® Alteon® Short Tapered Wedge
K221323 · Exactech, Inc. · May 2023
BENCOX Delta Option Heads
K223828 · Corentec Co., Ltd. · Mar 2023
ARTICUL/EZE Ceramic Heads
K222296 · Depuy Ireland UC · Jan 2023